Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230876 · ClinicalTrials.gov registry record · Phase 1
Auditory Training and Hearing Aid Satisfaction
A Phase 1 study of Hearing Impairment, Sensorineural, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04230876: Completed Phase 1 study of Hearing Impairment, Sensorineural, sponsored by Washington University School of Medicine.
NCT04230876 is a Phase 1 study of Hearing Impairment, Sensorineural that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants, below the 161-participant average among 3 other Hearing Impairment, Sensorineural trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04230876, a Phase 1 study of Hearing Impairment, Sensorineural, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Although hearing aids are the most common treatment for hearing loss, and have the potential to help seniors stay active and productive, almost 50% of them who receive hearing aids rarely if ever use them, a state of affairs sometimes referred to as "the hearing aid in the drawer" syndrome. clEAR's customized auditory brain training has been shown to be effective in improving adults' abilities to recognize speech, in reducing their perceptual effort associated with listening with a hearing loss, and in increasing their confidence to engage in everyday conversations. In the proposed research, we will determine whether older adults who receive hearing aids for the first time report higher satisfaction with their new hearing aids and have longer daily use time as a result of having completed clEAR's auditory brain training program for new hearing aid users.
Primary Outcome
The Client Orientated Scale of Improvement (COSI), a subjective measure of improvement on self-defined goals. The scale is relative to a baseline assessed before wearing hearing aids. For each goal participants select from a scale of improvement including Worse (-1), No Difference (0), Slightly Better (+1), Better (+2), and Much Better (+3). Positive values between one and three indicate improvement, negative values indicate that the self-defined goals got worse, and zero is no improvement. COSI
Conditions Studied
Interventions
- BEHAVIORAL Auditory Brian Training Games/Activities
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2021-02-28 |
| Phase | Phase 1 |
What the finished NCT04230876 record still lists
NCT04230876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 161-participant average among 3 other Hearing Impairment, Sensorineural trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Hearing Impairment, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which Auditory Brian Training Games/Activities is the first listed.
NCT04230876 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04230876 about?
NCT04230876 is a clinical study titled "Auditory Training and Hearing Aid Satisfaction". Although hearing aids are the most common treatment for hearing loss, and have the potential to help seniors stay active and productive, almost 50% of them who receive hearing aids rarely if ever use them, a state of affairs sometimes referred to as "the hearing aid in the drawer" syndrome. clEAR's ...
What is the current status of trial NCT04230876?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2020-09-01. Estimated completion is 2021-02-28.
What conditions does trial NCT04230876 study?
This clinical trial studies the following conditions: Hearing Impairment, Sensorineural.
What interventions are being tested in trial NCT04230876?
The interventions under investigation include: Auditory Brian Training Games/Activities (BEHAVIORAL).
Who is sponsoring clinical trial NCT04230876?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04230876 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Impairment, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
RECRUITING · Phase 1
-
Understanding Aided Speech Perception in Noise
RECRUITING · NA
-
A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation and Sound Coding in Adults.
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI